Globeflex Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-12,332
| Closed | -$1.72M | – | 415 |
|
|
2026
Q1 | $1.72M | Hold |
12,332
| – | – | 0.26% | 105 |
|
|
2025
Q4 | $1.51M | Hold |
12,332
| – | – | 0.23% | 112 |
|
|
2025
Q3 | $1.37M | Sell |
12,332
-365,215
| -97% | -$41.5M | 0.21% | 127 |
|
|
2025
Q2 | $41.9M | Hold |
377,547
| – | – | 3.47% | 1 |
|
|
2025
Q1 | $42.3M | Sell |
377,547
-27,058
| -7% | -$2.79M | 3.91% | 1 |
|
|
2024
Q4 | $37.4M | Buy |
404,605
+191,901
| +90% | +$17.3M | 3.17% | 2 |
|
|
2024
Q3 | $17.8M | Hold |
212,704
| – | – | 1.71% | 10 |
|
|
2024
Q2 | $14.6M | Sell |
212,704
-46,601
| -18% | -$3.11M | 1.52% | 13 |
|
|
2024
Q1 | $19M | Sell |
259,305
-90,801
| -26% | -$6.98M | 1.85% | 8 |
|
|
2023
Q4 | $28.4M | Hold |
350,106
| – | – | 2.9% | 5 |
|
|
2023
Q3 | $26.2M | Hold |
350,106
| – | – | 3.07% | 3 |
|
|
2023
Q2 | $27M | Hold |
350,106
| – | – | 3.01% | 4 |
|
|
2023
Q1 | $29M | Hold |
350,106
| – | – | 3.55% | 2 |
|
|
2022
Q4 | $30.1M | Buy |
350,106
+186,700
| +114% | +$14.8M | 3.81% | 1 |
|
|
2022
Q3 | $10.1M | Buy |
163,406
+161,574
| +8,820% | +$10.2M | 1.73% | 5 |
|
|
2022
Q2 | $113K | Hold |
1,832
| – | – | 0.03% | 376 |
|
|
2022
Q1 | $109K | Buy |
+1,832
| New | +$117K | 0.02% | 397 |
|
|
2021
Q4 | – | Sell |
-95
| Closed | -$7K | – | 475 |
|
|
2021
Q3 | $7K | Hold |
95
| – | – | ﹤0.01% | 412 |
|
|
2021
Q2 | $7K | Hold |
95
| – | – | ﹤0.01% | 429 |
|
|
2021
Q1 | $6K | Hold |
95
| – | – | ﹤0.01% | 428 |
|
|
2020
Q4 | $6K | Hold |
95
| – | – | ﹤0.01% | 440 |
|
|
2020
Q3 | $6K | Hold |
95
| – | – | ﹤0.01% | 433 |
|
|
2020
Q2 | $7K | Hold |
95
| – | – | ﹤0.01% | 451 |
|
|
2020
Q1 | $7K | Hold |
95
| – | – | ﹤0.01% | 451 |
|
|
2019
Q4 | $6K | Hold |
95
| – | – | ﹤0.01% | 461 |
|
|
2019
Q3 | $6K | Hold |
95
| – | – | ﹤0.01% | 442 |
|
|
2019
Q2 | $6K | Buy |
+95
| New | +$6.25K | ﹤0.01% | 436 |
|
|
2014
Q3 | – | Sell |
-42
| Closed | -$3K | – | 595 |
|
|
2014
Q2 | $3K | Buy |
42
+22
| +110% | +$1.71K | ﹤0.01% | 419 |
|
|
2014
Q1 | $1K | Hold |
20
| – | – | ﹤0.01% | 511 |
|
|
2013
Q4 | $1K | Buy |
+20
| New | +$1.39K | ﹤0.01% | 512 |
|
Other funds holding GILD
Globeflex Capital's GILD Position: Q2 2026 in Review
Globeflex Capital sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 12,332 shares — an estimated $1.72M sold.
Globeflex Capital first reported a position in GILD in Q4 2013 and held it in 30 quarters. The position peaked at $42.3M in Q1 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Globeflex Capital reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
- Globeflex Capital sold 12,332 Gilead Sciences shares in Q2 2026, an estimated $1.72M.
- Globeflex Capital first reported a position in Gilead Sciences in Q4 2013 and held it in 30 quarters.
- Globeflex Capital's Gilead Sciences position peaked at $42.3M in Q1 2025.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.